tiprankstipranks
Advertisement
Advertisement

LXRX Stock Latest News

Lexicon Pharmaceuticals: Buy Rating Reiterated as Value Catalysts Build; $6 Price Target Maintained
RatingsLexicon Pharmaceuticals: Buy Rating Reiterated as Value Catalysts Build; $6 Price Target Maintained
2d ago
LXRX
Lexicon reports Q1 EPS 0c, consensus (4c)
PremiumThe Fly
Lexicon reports Q1 EPS 0c, consensus (4c)
2d ago
LXRX
Lexicon Pharmaceuticals Secures New Hercules Term Loan Facility
PremiumCompany Announcements
Lexicon Pharmaceuticals Secures New Hercules Term Loan Facility
3d ago
8K
LXRX
Lexicon Shareholders Approve New Equity Plans, Capital Increase
PremiumCompany Announcements
Lexicon Shareholders Approve New Equity Plans, Capital Increase
9d ago
8K
LXRX
Lexicon Pharmaceuticals (LXRX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Lexicon Pharmaceuticals (LXRX) Q1 Earnings Cheat Sheet
12d ago
LXRX
Lexicon to present data at AAN annual meeting on Progress Phase 2b study
PremiumThe FlyLexicon to present data at AAN annual meeting on Progress Phase 2b study
23d ago
LXRX
Lexicon COGT reports Q1 EPS $2.07, consensus $1.74
Premium
The Fly
Lexicon COGT reports Q1 EPS $2.07, consensus $1.74
23d ago
LXRX
Lexicon, Novo Nordisk announce initiation of LX9851 study
Premium
The Fly
Lexicon, Novo Nordisk announce initiation of LX9851 study
2M ago
NVO
LXRX
Lexicon announces results from post hoc analysis on data of sotagliflozin
PremiumThe Fly
Lexicon announces results from post hoc analysis on data of sotagliflozin
2M ago
LXRX
Lexicon price target raised to $2.30 from $2.10 at Citi
PremiumThe Fly
Lexicon price target raised to $2.30 from $2.10 at Citi
2M ago
LXRX
Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones
PremiumCompany Announcements
Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones
2M ago
LXRX
Lexicon price target raised to $6 from $4 at H.C. Wainwright
PremiumThe Fly
Lexicon price target raised to $6 from $4 at H.C. Wainwright
2M ago
LXRX
Lexicon reports Q4 EPS (4c), consensus (7c)
PremiumThe FlyLexicon reports Q4 EPS (4c), consensus (7c)
2M ago
LXRX
LXRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LXRX Earnings this Week: How Will it Perform?
2M ago
LXRX
Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing
Premium
Company Announcements
Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing
3M ago
8K
LXRX
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
PremiumThe Fly
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
3M ago
V
CL
Lexicon 32M share Spot Secondary priced at $1.30
PremiumThe Fly
Lexicon 32M share Spot Secondary priced at $1.30
3M ago
LXRX
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
PremiumCompany Announcements
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
3M ago
8K
LXRX
Lexicon announces common stock offering, no amount given
PremiumThe Fly
Lexicon announces common stock offering, no amount given
3M ago
LXRX
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
PremiumThe FlyMidday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
4M ago
DB
ANF
Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin
Premium
The Fly
Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin
4M ago
LXRX
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
Premium
Ratings
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
4M ago
LXRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >